Normal Saline along with standard treatment: Clinical Trials

5 trials of Normal Saline along with standard treatment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 2
Phase 31Completed 1

Follow Normal Saline along with standard treatment: new trials by email Literature Review of Normal Saline along with standard treatment trials Research Report on Normal Saline along with standard treatment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Normal Saline along with standard treatment, Sovateltide along with standard treatment - Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia
Phase 2RecruitingPharmazz, Inc.402023-09-062025-12-31
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Normal Saline along with standard treatment, PMZ-1620 (sovateltide) along with standard treatment - Cerebral Ischemia, Cerebral Infarction
Phase 3CompletedPharmazz, Inc.1582019-11-102023-10-18
PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
Normal Saline along with standard treatment, PMZ-1620 along with standard treatment - Acute Spinal Cord Injury
Phase 2RecruitingPharmazz, Inc.402019-01-102025-07-04
PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease
Normal Saline along with standard treatment, PMZ-1620 (sovateltide) along with standard treatment - Alzheimer Disease, Dementia
Phase 2CompletedPharmazz, Inc.802018-03-232023-01-12
PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Normal Saline along with standard treatment, PMZ-1620 along with standard treatment - Acute Stroke, Cerebral Ischemia
Phase 2CompletedPharmazz, Inc.402018-01-192025-05-12

Conditions studied

Brain Ischemia (2)  ·  Stroke (2)  ·  Alzheimer Disease (1)  ·  Asphyxia Neonatorum (1)  ·  Cerebral Infarction (1)  ·  Dementia (1)  ·  Hypoxia-Ischemia, Brain (1)

Sponsors

Pharmazz, Inc. (5)

Countries

India (5)

Top investigators

Anil Gulati (4)  ·  Anil Gulati, MD, PhD (1)

Results publications

PMID 33428177, PMID 39542995